Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001558370-22-005656
Filing Date
2022-04-20
Accepted
2022-04-20 17:00:11
Documents
2
Period of Report
2022-06-21

Document Format Files

Seq Description Document Type Size
1 PRE 14A tmb-20220621xpre14a.htm PRE 14A 846887
2 GRAPHIC tmb-20220621xpre14a001.jpg GRAPHIC 6520
  Complete submission text file 0001558370-22-005656.txt   857179
Mailing Address 1111 KANE CONCOURSE SUITE 301 BAY HARBOR ISLANDS FL 33154
Business Address 1111 KANE CONCOURSE SUITE 301 BAY HARBOR ISLANDS FL 33154 781-652-4500
Fortress Biotech, Inc. (Filer) CIK: 0001429260 (see all company filings)

EIN.: 205157386 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-35366 | Film No.: 22838800
SIC: 2834 Pharmaceutical Preparations